Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques (Q57089576)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

article

Language	Label	Description	Also known as
English	Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques	article

Statements

scholarly article

0 references

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques (English)

0 references

object named as

Zdenek Hel

1

0 references

David I Watkins

10

object named as

David Watkins

0 references

author name string

David Venzon

2

0 references

Monita Poudyal

3

0 references

Wen-Po Tsai

4

0 references

Laura Giuliani

5

0 references

Ruth Woodward

6

0 references

Claire Chougnet

7

0 references

Gene Shearer

8

0 references

John D. Altman

9

0 references

Norbert Bischofberger

11

0 references

Alashle Abimiku

12

0 references

Phillip Markham

13

0 references

James Tartaglia

14

0 references

Genoveffa Franchini

15

0 references

language of work or name

0 references

publication date

October 2000

0 references

Nature Medicine

0 references

6

0 references

10

0 references

1140-1146

0 references

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics

1 reference

https://api.crossref.org/works/10.1038%2F80481

21 January 2018

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2F80481

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1038%2F80481

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1038%2F80481

7 January 2021

based on heuristic

inferred from DOI database lookup

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1038%2F80481

7 January 2021

based on heuristic

inferred from DOI database lookup

The CD8+ T lymphocyte response during primary SIVmac infection

1 reference

https://api.crossref.org/works/10.1038%2F80481

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57089576&oldid=2213296417"